The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
Randall K. Fields, the Chief Executive Officer of ReposiTrak, Inc. (NASDAQ:TRAK), recently sold 7,500 shares of the company's common stock. The transaction, which took place on January 21, 2025, was ...